(19)
(11) EP 1 097 226 A1

(12)

(43) Date of publication:
09.05.2001 Bulletin 2001/19

(21) Application number: 99927635.5

(22) Date of filing: 07.07.1999
(51) International Patent Classification (IPC)7C12N 15/57, C12N 5/10, C12N 1/21, C12N 9/64, C07K 16/40, G01N 33/50
(86) International application number:
PCT/CA9900/615
(87) International publication number:
WO 0003/023 (20.01.2000 Gazette 2000/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.07.1998 US 92005 P

(71) Applicant: Merck Frosst Canada & Co.
Kirkland, Quebec H9H 3L1 (CA)

(72) Inventors:
  • NICHOLSON, Donald, W.
    Kirkland, Quebec H9H 3L1 (CA)
  • RASPER, Dita, M.
    Kirkland, Quebec H9H 3L1 (CA)
  • XANTHOUDAKIS, Steve
    Kirkland, Quebec H9H 3L1 (CA)
  • ROY, Sophie
    Kirkland, Quebec H9H 3L1 (CA)

(74) Representative: Horgan, James Michael Frederic 
Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) USURPIN, A MAMMALIAN DED-CASPASE HOMOLOGUE THAT PRECLUDES CASPASE-8 RECRUITMENT AND ACTIVATION BY THE CD-95 (FAS, APO-1) RECEPTOR COMPLEX